US Broker Ratings

Metsera, Inc. (MTSR) Stock Analysis: A Clinical-Stage Biotech with a -19.15% Potential Downside

Metsera, Inc. (MTSR) is a clinical-stage biotechnology company making strides in the healthcare sector, especially in the fight against obesity and related metabolic disorders. Incorporated in..

Surgery Partners, Inc. (SGRY) Stock Analysis: Evaluating a 45% Upside Potential in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Brentwood, Tennessee, the..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 36.99% Upside Potential

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the healthcare sector, specializes in the development, manufacturing, and distribution of essential medical instruments and supplies. With..

Zai Lab Limited (ZLAB): Analyst Consensus Suggests Over 100% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB), a notable player in the biotechnology sector, is capturing attention with its promising growth potential and strategic collaborations. With a market..

Arcellx, Inc. (ACLX) Stock Analysis: Strong Pipeline but Challenging Financials

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company specializing in innovative immunotherapies, is currently navigating a complex financial landscape while advancing its promising clinical pipeline. With a..

Soleno Therapeutics (SLNO) Investor Outlook: Biotech Stock Poised for a Potential 170% Upside

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing investor attention with a standout potential upside of 170.63%, according to recent analyst ratings. This biopharmaceutical company, headquartered in..

Sarepta Therapeutics (SRPT) Stock Analysis: Is There a 21.77% Upside for Biotech Investors?

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, is capturing investor attention with its strategic focus on RNA-targeted therapeutics and gene therapy for..

Repligen Corporation (RGEN) Stock Analysis: Uncovering a 55% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the Healthcare sector, has been making waves in the Medical Instruments & Supplies industry. With a market capitalization..

Integer Holdings Corporation (ITGR) Stock Analysis: Uncovering a 10% Potential Upside in Medical Devices

Integer Holdings Corporation (NYSE: ITGR) stands as a key player in the medical devices sector, offering a diverse portfolio of products and services. With a market..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A Deep Dive into a Promising 72% Potential Upside

iRhythm Holdings, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector, specifically within the medical devices industry. Specializing in innovative cardiac monitoring solutions, iRhythm has..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 9.28% Upside Potential

Bausch + Lomb Corporation (NYSE: BLCO) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Promising 23.47% Potential Upside in Genetic Medicine

Krystal Biotech, Inc. (NASDAQ: KRYS) is swiftly carving out a significant niche in the healthcare sector with its groundbreaking genetic medicines. As a commercial-stage biotechnology company..

Incyte Corporation (INCY): Investor Outlook Reveals a 13.38% Potential Upside Amidst Robust Revenue Growth

Incyte Corporation (NASDAQ: INCY) stands out in the biotechnology sector as a formidable player, given its strategic focus on developing and commercializing innovative therapies. With a..

The Cooper Companies, Inc. (COO) Investor Outlook: Potential Upside of Nearly 19% Amid Strong Buy Ratings

For investors seeking opportunities in the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents a compelling case. As a leader in the medical instruments and..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring a Promising 11.27% Potential Upside

Oscar Health, Inc. (NYSE: OSCR) has been making waves in the healthcare sector with its innovative approach to health insurance and technology. As a healthcare technology..

Viatris Inc. (VTRS) Investor Outlook: Evaluating a Stock with a 9.46% Potential Upside

Viatris Inc. (VTRS) presents an intriguing opportunity for investors looking to diversify within the healthcare sector, particularly in the realm of specialty and generic drug manufacturing...

Masimo Corporation (MASI) Stock Analysis: Evaluating Growth Potential Amid Healthcare Innovation

Masimo Corporation (MASI), a prominent player in the healthcare sector, is making waves in the medical devices industry with its cutting-edge patient monitoring technologies. Headquartered in..

RadNet, Inc. (RDNT) Stock Analysis: Potential 52% Upside in Healthcare Diagnostics

RadNet, Inc. (RDNT), a prominent player in the healthcare sector specializing in diagnostics and research, has been capturing the attention of investors with its robust growth..

Legend Biotech Corporation (LEGN) Stock Analysis: Unpacking a 209% Potential Upside in Biotech

Legend Biotech Corporation (NASDAQ: LEGN) is creating a buzz among investors with its remarkable potential upside, estimated at 209.42%. This biopharmaceutical company, headquartered in Somerset, New..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unlocking a 23.31% Potential Upside in the Diagnostics Sector

Investors seeking opportunities in the healthcare sector, particularly in the diagnostics and research industry, should consider IDEXX Laboratories, Inc. (NASDAQ: IDXX). With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds